Objectives: To review cytomorphologic characteristics of osteoblastic osteosarcoma (OOS), a variant of osteosarcoma, on fine-needle aspiration (FNA) and correlate them with histopathologic features and clinical outcomes. Study design: A retrospective review of the cytopathology archives of The Johns Hopkins Hospital revealed 22 cases of OOS on FNA in 20 patients (16 primary, 5 recurrent and 1 metastatic OOS). Results: There were 11 males and 9 females (male:female ratio 4:3) aged from 5 to 48 years (mean 17.1). Anatomic locations were: femur (7), humerus (3), tibia (4), fibula (1), iliac crest (1), pubis (1), sacrum (1), mandible (1) and soft tissue of the thigh (3). All except 1 presented with progressive pain and/or swelling. Sizes of the lesions ranged from 2.3 to 34 cm (mean 9.2). Initial FNA diagnoses were high-grade malignant neoplasm (5), osteosarcoma, non-conventional osteosarcoma (12) and OOS (5). Cytomorphologic characteristics were: moderate-high cellularity, discohesive/single cells, small tissue fragments, immature osteoid, bi-/multinucleated giant cells, plasmacytoid cells with basophilic, vacuolated cytoplasm, round to oval nuclei and macronucleoli. Cases with high-grade histology displayed pleomorphism and mitoses. Conclusions: OOS has a better prognosis than other osteosarcoma variants. The differential diagnosis of OOS includes reactive bone lesions, osteoblastoma, malignant sarcoma with an osteoid component and other osteosarcoma variants. A definitive diagnosis can be made on FNA with clinical and radiological correlation, thus facilitating immediate therapy.

1.
Fletcher CDM, Unni KK, Mertens F (eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, IARC, 2002, pp 265–270.
2.
Fagioli F, Biasin E, Mereuta OM, Muraro M, Luksch R, Ferrari S, Aglietta M, Madon E: Poor prognosis osteosarcoma: new therapeutic approach (review). Bone Marrow Transplant 2008;41(suppl 2):S131–S134.
3.
Akerman M, Dreinhöfer K, Rydholm A, Willén H, Mertens F, Mitelman F, Mandahl N: Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing’s sarcoma. Diagn Cytopathol 1996;15:17–22.
4.
White VA, Fanning CV, Ayala AG, Raymond AK, Carrasco CH, Murray JA: Osteosarcoma and the role of fine-needle aspiration. A study of 51 cases. Cancer 1988;62:1238–1246.
5.
Layfield LJ, Armstrong K, Zaleski S, Eckardt J: Diagnostic accuracy and clinical utility of fine-needle aspiration cytology in the diagnosis of clinically primary bone lesions. Diagn Cytopathol 1993;9:168–173.
6.
Dodd LG, Scully SP, Cothran RL, Harrelson JM: Utility of fine-needle aspiration in the diagnosis of primary osteosarcoma. Diagn Cytopathol 2002;27:350–353.
7.
Söderlund V, Skoog L, Unni KK, Bertoni F, Brosjö O, Kreicbergs A.: Diagnosis of high-grade osteosarcoma by radiology and cytology: a retrospective study of 52 cases. Sarcoma 2004;8:31–36.
8.
Unni KK, Dahlin DC: Osteosarcoma: pathology and classification. Semin Roentgenol 1989;24:143–152.
9.
Hegyi M, Semsei AF, Jakab Z, Antal I, Kiss J, Szendroi M, Csoka M, Kovacs G: Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer 2011;57:415–422.
10.
Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jung ST, Jeon DG: Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response. J Orthop Sci 2009;14:292–297.
11.
Bishop JA, Shum CH, Sheth S, Wakely PE Jr, Ali SZ: Small cell osteosarcoma: cytopathologic characteristics and differential diagnosis. Am J Clin Pathol 2010;133:756–761.
12.
Bispo RZ Jr, Camargo OP: Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy. Clinics (Sao Paulo) 2009;64:1177–1186.
13.
Bacci G, Bertoni F, Longhi A, Ferrari S, Forni C, Biagini R, Bacchini P, Donati D, Manfrini M, Bernini G, Lari S: Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer 2003;97:3068–3075.
14.
Domanski HA, Akerman M: Fine-needle aspiration of primary osteosarcoma: a cytological-histological study. Diagn Cytopathol 2005;32:269–275.
15.
Daneshbod Y, Khademi B: Mandibular osteosarcoma: a diagnostic pitfall on aspiration cytology of the salivary glands. Cytopathology 2009;20:136–139.
16.
Dodd LG, Martinez S: Fine-needle aspiration cytology of pseudosarcomatous lesions of soft tissue. Diagn Cytopathol 2001;24:28–35.
17.
Barwad A, Banik T, Gorsi U, Dey P: Fine needle aspiration cytology of myositis ossificans. Diagn Cytopathol 2011;39:432–434.
18.
Wakely PE Jr, Almeida M, Frable WJ: Fine-needle aspiration biopsy cytology of myositis ossificans. Mod Pathol 1994;7:23–25.
19.
Estrada-Villasenor E, Cedillo ED, Martinez GR: Scrape cytology of myositis ossificans: report of a case and analysis of the cytologic findings described previously. Diagn Cytopathol 2008;36:50–53.
20.
Akerman M, Domanski HA, Jonsson : Cytological features of bone tumours in FNA smears I: osteogenic tumours. Monogr Clin Cytol 2010;19:18–30.
21.
Rhode MG, Lucas DR, Krueger CH, Pu RT: Fine-needle aspiration of spinal osteoblastoma in a patient with lymphangiomatosis. Diagn Cytopathol 2006;34:295–297.
22.
Akerman M, Domanski HA, Jonsson K: Cytological features of bone tumours in FNA smears II: cartilaginous tumours. Monogr Clin Cytol 2010;19:31–44.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.